260 related articles for article (PubMed ID: 9247204)
1. The validity of melatonin as an oncostatic agent.
Panzer A; Viljoen M
J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
3. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.
Blask DE; Sauer LA; Dauchy RT
Curr Top Med Chem; 2002 Feb; 2(2):113-32. PubMed ID: 11899096
[TBL] [Abstract][Full Text] [Related]
4. Basic mechanisms involved in the anti-cancer effects of melatonin.
Mediavilla MD; Sanchez-Barcelo EJ; Tan DX; Manchester L; Reiter RJ
Curr Med Chem; 2010; 17(36):4462-81. PubMed ID: 21062257
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
[TBL] [Abstract][Full Text] [Related]
6. Melatonin's Antineoplastic Potential Against Glioblastoma.
Moretti E; Favero G; Rodella LF; Rezzani R
Cells; 2020 Mar; 9(3):. PubMed ID: 32138190
[TBL] [Abstract][Full Text] [Related]
7. ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin's oncostatic action on ER+ breast cancer cell proliferation.
Liburdy RP; Sloma TR; Sokolic R; Yaswen P
J Pineal Res; 1993 Mar; 14(2):89-97. PubMed ID: 8320637
[TBL] [Abstract][Full Text] [Related]
8. Melatonin in cancer management: progress and promise.
Jung B; Ahmad N
Cancer Res; 2006 Oct; 66(20):9789-93. PubMed ID: 17047036
[TBL] [Abstract][Full Text] [Related]
9. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
[TBL] [Abstract][Full Text] [Related]
10. Oncostatic action of melatonin: facts and question marks.
Pawlikowski M; Winczyk K; Karasek M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():24-9. PubMed ID: 12019348
[TBL] [Abstract][Full Text] [Related]
11. Melatonin and mammary cancer: a short review.
Sánchez-Barceló EJ; Cos S; Fernández R; Mediavilla MD
Endocr Relat Cancer; 2003 Jun; 10(2):153-9. PubMed ID: 12790777
[TBL] [Abstract][Full Text] [Related]
12. Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat.
Cini G; Coronnello M; Mini E; Neri B
Cancer Lett; 1998 Mar; 125(1-2):51-9. PubMed ID: 9566696
[TBL] [Abstract][Full Text] [Related]
13. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy.
Targhazeh N; Reiter RJ; Rahimi M; Qujeq D; Yousefi T; Shahavi MH; Mir SM
Biochimie; 2022 Nov; 202():34-48. PubMed ID: 35752221
[TBL] [Abstract][Full Text] [Related]
14. Melatonin: from basic research to cancer treatment clinics.
Vijayalaxmi ; Thomas CR; Reiter RJ; Herman TS
J Clin Oncol; 2002 May; 20(10):2575-601. PubMed ID: 12011138
[TBL] [Abstract][Full Text] [Related]
15. Effect and mechanism of melatonin's action on the proliferation of human umbilical vein endothelial cells.
Cui P; Luo Z; Zhang H; Su Y; Li A; Li H; Zhang J; Yang Z; Xiu R
J Pineal Res; 2006 Nov; 41(4):358-62. PubMed ID: 17014693
[TBL] [Abstract][Full Text] [Related]
16. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
[TBL] [Abstract][Full Text] [Related]
17. Melatonin and cisplatin co-treatment against cancer: A mechanistic review of their synergistic effects and melatonin's protective actions.
Rafiyan M; Davoodvandi A; Reiter RJ; Mansournia MA; Rasooli Manesh SM; Arabshahi V; Asemi Z
Pathol Res Pract; 2024 Jan; 253():155031. PubMed ID: 38103362
[TBL] [Abstract][Full Text] [Related]
18. Does the use of melatonin overcome drug resistance in cancer chemotherapy?
Asghari MH; Ghobadi E; Moloudizargari M; Fallah M; Abdollahi M
Life Sci; 2018 Mar; 196():143-155. PubMed ID: 29374563
[TBL] [Abstract][Full Text] [Related]
19. The potential utility of melatonin in the treatment of childhood cancer.
Chao YH; Wu KH; Yeh CM; Su SC; Reiter RJ; Yang SF
J Cell Physiol; 2019 Nov; 234(11):19158-19166. PubMed ID: 30945299
[TBL] [Abstract][Full Text] [Related]
20. Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation.
Sanchez-Barcelo EJ; Mediavilla MD; Alonso-Gonzalez C; Reiter RJ
Expert Opin Investig Drugs; 2012 Jun; 21(6):819-31. PubMed ID: 22500582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
